Bulletin
Investor Alert

New York Markets Open in:

Immunogen Inc.

NAS: IMGN

GO
/marketstate/country/us

After Hours

/zigman2/quotes/208003500/composite

$

4.50

Change

+0.11 +2.51%

Volume

Volume 31,294

Jun 27, 2022, 7:57 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/208003500/composite

Previous close

$ 4.31

$ 4.39

Change

+0.08 +1.86%

Day low

Day high

$4.23

$4.45

Open
Open: 4.36

52 week low

52 week high

$3.10

$7.77

Open

Market cap

$950.51M

Average volume

3.82M

P/E ratio

N/A

Rev. per Employee

$659,019

EPS

-0.60

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/imgn

MarketWatch News on IMGN

  1. ImmunoGen shares jump 7% premarket

    7:35 a.m. Feb. 15, 2022

    - Ciara Linnane

  2. ImmunoGen unveils license agreement of Novel Camptothecin ADC Platform with Eli Lilly for up to $1.7 bln

    7:34 a.m. Feb. 15, 2022

    - Ciara Linnane

  3. ImmunoGen will receive an initial upfront payment of $13 mln, and up to $35 mln more for meeting targets

    7:35 a.m. Feb. 15, 2022

    - Ciara Linnane

  4. Immunogen started at outperform with $18 stock price target at BMO Capital

    2:51 p.m. Feb. 11, 2022

    - Tomi Kilgore

  5. Bed Bath & Beyond and 3 more stocks showing momentum

    1:50 p.m. Dec. 19, 2019

    - Harry Boxer

  6. ImmunoGen shares rise on ovarian cancer study

    5:00 p.m. Dec. 17, 2019

    - Jaimy Lee

  7. Immunogen's stock plunges 30% premarket after FDA recommends new phase 3 trial of cancer treatment

    7:49 a.m. May 15, 2019

    - Tomi Kilgore

  8. Immunogen downgraded to underweight from neutral at J.P. Morgan

    6:55 a.m. March 19, 2019

    - Tomi Kilgore

  9. The Dow Bounces Back Because No News Is Good News — for Now

    12:57 p.m. March 5, 2019

    - Barron's Online

  10. Immunogen upgraded to equal weight at Morgan Stanley

    10:55 a.m. March 5, 2019

    - Tomi Kilgore

  11. Immunogen stock the most actively traded on major U.S. exchanges, with volume above 13.8 mln shares

    10:50 a.m. March 1, 2019

    - Tomi Kilgore

  12. Immunogen's stock plummets 50% to pace all NYSE, Nasdaq decliners

    10:49 a.m. March 1, 2019

    - Tomi Kilgore

  13. Immunogen's stock plunges on premarket-leading trading volume of 3.2 mln shares

    9:20 a.m. March 1, 2019

    - Tomi Kilgore

  14. Immunogen's stock extends loss, plunges 50.2% premarket after failed trial

    9:20 a.m. March 1, 2019

    - Tomi Kilgore

  15. Loading more headlines...

Analyst Ratings

/news/nonmarketwatch/company/us/imgn

Other News on IMGN

  1. ImmunoGen (IMGN) Investor Presentation - Slideshow

    3:00 p.m. May 24, 2022

    - Seeking Alpha

  2. INO, WWR and CTIC among pre market gainers

    8:28 a.m. May 23, 2022

    - Seeking Alpha

  3. ImmunoGen: An Inflection Point In Growth

    4:16 p.m. May 17, 2022

    - Seeking Alpha

  4. ImmunoGen (IMGN) Q1 2022 Earnings Call Transcript

    1:30 p.m. May 6, 2022

    - Motley Fool

  5. 10-Q: IMMUNOGEN, INC.

    11:49 a.m. May 6, 2022

    - Edgar Online - (EDG = 10Q, 10K)

  6. ImmunoGen Q1 2022 Earnings Preview

    11:30 a.m. May 5, 2022

    - Seeking Alpha

  7. Notable earnings before Friday's open

    10:41 a.m. May 5, 2022

    - Seeking Alpha

  8. ImmunoGen: Way Beyond SORAYA

    10:35 a.m. April 10, 2022

    - Seeking Alpha

  9. Is ImmunoGen Stock a Bargain After Dropping 39%?

    11:23 a.m. April 1, 2022

    - Motley Fool

  10. ImmunoGen (IMGN) Files BLA for Lead Drug in Ovarian Cancer

    11:51 a.m. March 30, 2022

    - Zacks.com

  11. Loading more headlines...
/news/pressrelease/company/us/imgn

Press Releases on IMGN

  1. ImmunoGen Announces Webcasts of Presentations at Upcoming Conferences

    4:30 p.m. May 25, 2022

    - BusinessWire - BZX

  2. Loading more headlines...

Rates »

Link to MarketWatch's Slice.